News

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
HIV/AIDS patients challenging CVS Pharmacy Inc.'s policy of distributing specialty drugs through the mail failed to secure ...
As with many chronic and often deadly diseases, an ounce of prevention can be worth a ton of cure. It's a breakthrough drug ...
The Manila Times on MSN3d
HIV-prevention drug wins FDA approval
THE United States Food and Drug Administration (FDA) on Wednesday approved Gilead Sciences' lenacapavir, a drug to be injected twice annually, for preventing HIV infection in adults and adolescents at ...
Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
The Food and Drug Administration has approved ... The shot is the first in a new class of antiretrovirals which block HIV from infecting and making new copies of itself inside the immune cells ...